Mitoxantrone Terminated Phase 2 Trials for Relapsing Remitting Multiple Sclerosis (RRMS)

IndicationsStatusPurposePhase
TerminatedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00219908Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis